-
1
-
-
79954621581
-
Glaucoma
-
H.A. Quigley Glaucoma Lancet 377 2011 1367 1377
-
(2011)
Lancet
, vol.377
, pp. 1367-1377
-
-
Quigley, H.A.1
-
2
-
-
79953183017
-
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue
-
J.J. Servat, and C.R. Bernardino Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue Drug Aging 28 2011 267 282
-
(2011)
Drug Aging
, vol.28
, pp. 267-282
-
-
Servat, J.J.1
Bernardino, C.R.2
-
3
-
-
84871307452
-
Pharmacological management of ocular hypertension: Current approaches and future prospective
-
C. Bucolo, S. Salomone, F. Drago, M. Reibaldi, A. Longo, and M.G. Uva Pharmacological management of ocular hypertension: current approaches and future prospective Curr Opin Pharmacol 13 2013 50 55
-
(2013)
Curr Opin Pharmacol
, vol.13
, pp. 50-55
-
-
Bucolo, C.1
Salomone, S.2
Drago, F.3
Reibaldi, M.4
Longo, A.5
Uva, M.G.6
-
4
-
-
77956187508
-
Electronic compliance monitoring of topical treatment after ophthalmic surgery
-
M.M. Hermann, C. Ustundag, and M. Diestelhorst Electronic compliance monitoring of topical treatment after ophthalmic surgery Int Ophthalmol 30 2010 385 390
-
(2010)
Int Ophthalmol
, vol.30
, pp. 385-390
-
-
Hermann, M.M.1
Ustundag, C.2
Diestelhorst, M.3
-
5
-
-
0028997927
-
Compliance in patients prescribed eyedrops for glaucoma
-
S.C. Patel, and G.L. Spaeth Compliance in patients prescribed eyedrops for glaucoma Ophthalmic Surg 26 1995 233 236
-
(1995)
Ophthalmic Surg
, vol.26
, pp. 233-236
-
-
Patel, S.C.1
Spaeth, G.L.2
-
6
-
-
26844475953
-
Persistence and adherence with topical glaucoma therapy
-
B.L. Nordstrom, D.S. Friedman, E. Mozaffari, H.A. Quigley, and A.M. Walker Persistence and adherence with topical glaucoma therapy Am J Ophthalmol 140 2005 598 606
-
(2005)
Am J Ophthalmol
, vol.140
, pp. 598-606
-
-
Nordstrom, B.L.1
Friedman, D.S.2
Mozaffari, E.3
Quigley, H.A.4
Walker, A.M.5
-
8
-
-
40949094794
-
Barriers to glaucoma drug delivery
-
D. Ghate, and H.F. Edelhauser Barriers to glaucoma drug delivery J Glaucoma 17 2008 147 156
-
(2008)
J Glaucoma
, vol.17
, pp. 147-156
-
-
Ghate, D.1
Edelhauser, H.F.2
-
9
-
-
0017026787
-
Visual effects of pilocarpine in glaucoma - Comparative-study of administration by eyedrops or by ocular therapeutic systems
-
H.S. Brown, G. Meltzer, R.C. Merrill, M. Fisher, C. Ferre, and V.A. Place Visual effects of pilocarpine in glaucoma - comparative-study of administration by eyedrops or by ocular therapeutic systems Arch Ophthalmol-Chic 94 1976 1716 1719
-
(1976)
Arch Ophthalmol-Chic
, vol.94
, pp. 1716-1719
-
-
Brown, H.S.1
Meltzer, G.2
Merrill, R.C.3
Fisher, M.4
Ferre, C.5
Place, V.A.6
-
10
-
-
0016731042
-
Pilocarpine ocusert system for sustained control of ocular hypertension
-
K.L. Macoul, and D. Pavan-Langston Pilocarpine ocusert system for sustained control of ocular hypertension Arch Ophthalmol 93 1975 587 590
-
(1975)
Arch Ophthalmol
, vol.93
, pp. 587-590
-
-
Macoul, K.L.1
Pavan-Langston, D.2
-
11
-
-
0032118985
-
A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: Patient preference and impact on daily life
-
K. Strohmaier, E. Snyder, and I. Adamsons A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life J Am Optom Assoc 69 1998 441 451
-
(1998)
J Am Optom Assoc
, vol.69
, pp. 441-451
-
-
Strohmaier, K.1
Snyder, E.2
Adamsons, I.3
-
12
-
-
47549087517
-
Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-Month results
-
R.S. Ramchandran, S. Fekrat, S.S. Stinnett, and G.J. Jaffe Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-Month results Am J Ophthalmol 146 2008 285 291
-
(2008)
Am J Ophthalmol
, vol.146
, pp. 285-291
-
-
Ramchandran, R.S.1
Fekrat, S.2
Stinnett, S.S.3
Jaffe, G.J.4
-
13
-
-
42149144030
-
Characteristics of patients who dropout from a glaucoma clinic
-
A.O. Ashaye, and A.O. Adeoye Characteristics of patients who dropout from a glaucoma clinic J Glaucoma 17 2008 227 232
-
(2008)
J Glaucoma
, vol.17
, pp. 227-232
-
-
Ashaye, A.O.1
Adeoye, A.O.2
-
14
-
-
33845407019
-
Brimonidine in the treatment of glaucoma and ocular hypertension
-
L.B. Cantor Brimonidine in the treatment of glaucoma and ocular hypertension Ther Clinical Risk Manage 2 2006 337 346
-
(2006)
Ther Clinical Risk Manage
, vol.2
, pp. 337-346
-
-
Cantor, L.B.1
-
15
-
-
84860681553
-
Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma
-
P. Bhagav, V. Trivedi, D. Shah, and S. Chandran Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma Drug Deliv Transl Res 1 2011 161 174
-
(2011)
Drug Deliv Transl Res
, vol.1
, pp. 161-174
-
-
Bhagav, P.1
Trivedi, V.2
Shah, D.3
Chandran, S.4
-
16
-
-
37549027605
-
Design of ocular inserts of brimonidine tartrate by response surface methodology
-
H.N. Shivakumar, B.G. Desai, P.G. Subhash, P. Ashok, and B. Hulakoti Design of ocular inserts of brimonidine tartrate by response surface methodology J Drug Deliv Sci Technol 17 2007 421 430
-
(2007)
J Drug Deliv Sci Technol
, vol.17
, pp. 421-430
-
-
Shivakumar, H.N.1
Desai, B.G.2
Subhash, P.G.3
Ashok, P.4
Hulakoti, B.5
-
17
-
-
83555160860
-
Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: Preparation and in vitro/in vivo evaluation
-
M.H. Aburahma, and A.A. Mahmoud Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation AAPS PharmSciTech 12 2011 1335 1347
-
(2011)
AAPS PharmSciTech
, vol.12
, pp. 1335-1347
-
-
Aburahma, M.H.1
Mahmoud, A.A.2
-
18
-
-
67650444052
-
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone
-
E. Barcia, R. Herrero-Vanrell, A. Diez, C. Alvarez-Santiago, I. Lopez, and M. Calonge Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone Exp Eye Res 89 2009 238 245
-
(2009)
Exp Eye Res
, vol.89
, pp. 238-245
-
-
Barcia, E.1
Herrero-Vanrell, R.2
Diez, A.3
Alvarez-Santiago, C.4
Lopez, I.5
Calonge, M.6
-
19
-
-
77949917853
-
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
-
H. Gupta, M. Aqil, R.K. Khar, A. Ali, A. Bhatnagar, and G. Mittal Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery Nanomed-Nanotechnol 6 2010 324 333
-
(2010)
Nanomed-Nanotechnol
, vol.6
, pp. 324-333
-
-
Gupta, H.1
Aqil, M.2
Khar, R.K.3
Ali, A.4
Bhatnagar, A.5
Mittal, G.6
-
20
-
-
84872330873
-
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits
-
T. Musumeci, C. Bucolo, C. Carbone, R. Pignatello, F. Drago, and G. Puglisi Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits Int J Pharm 440 2013 135 140
-
(2013)
Int J Pharm
, vol.440
, pp. 135-140
-
-
Musumeci, T.1
Bucolo, C.2
Carbone, C.3
Pignatello, R.4
Drago, F.5
Puglisi, G.6
-
21
-
-
79953839784
-
The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films
-
T.W.J. Steele, C.L. Huang, E. Widjaja, F.Y.C. Boey, J.S.C. Loo, and S.S. Venkatraman The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films Acta Biomater 7 2011 1973 1983
-
(2011)
Acta Biomater
, vol.7
, pp. 1973-1983
-
-
Steele, T.W.J.1
Huang, C.L.2
Widjaja, E.3
Boey, F.Y.C.4
Loo, J.S.C.5
Venkatraman, S.S.6
-
22
-
-
0036668786
-
Formulation effects on ocular absorption of brimonidine in rabbit eyes
-
A.A. Acheampong, D. Small, V. Baumgarten, D. Welty, and D. Tang-Liu Formulation effects on ocular absorption of brimonidine in rabbit eyes J Ocul Pharmacol Ther 18 2002 325 337
-
(2002)
J Ocul Pharmacol Ther
, vol.18
, pp. 325-337
-
-
Acheampong, A.A.1
Small, D.2
Baumgarten, V.3
Welty, D.4
Tang-Liu, D.5
-
23
-
-
0036320242
-
Why degradable polymers undergo surface erosion or bulk erosion
-
F. von Burkersroda, L. Schedl, and A. Gopferich Why degradable polymers undergo surface erosion or bulk erosion Biomaterials 23 2002 4221 4231
-
(2002)
Biomaterials
, vol.23
, pp. 4221-4231
-
-
Von Burkersroda, F.1
Schedl, L.2
Gopferich, A.3
-
24
-
-
34547131592
-
A field comparison of ethylene vinyl acetate and low-density polyethylene thin films for equilibrium phase passive air sampling of polycyclic aromatic hydrocarbons
-
K.E. Kennedy, D.W. Hawker, J.F. Müller, M.E. Bartkow, and R.W. Truss A field comparison of ethylene vinyl acetate and low-density polyethylene thin films for equilibrium phase passive air sampling of polycyclic aromatic hydrocarbons Atmos Environ 41 2007 5778 5787
-
(2007)
Atmos Environ
, vol.41
, pp. 5778-5787
-
-
Kennedy, K.E.1
Hawker, D.W.2
Müller, J.F.3
Bartkow, M.E.4
Truss, R.W.5
-
25
-
-
78649838345
-
A "tool box" for rational design of degradable controlled release formulations
-
S.N. Rothstein, and S.R. Little A "tool box" for rational design of degradable controlled release formulations J Mater Chem 21 2011 29 39
-
(2011)
J Mater Chem
, vol.21
, pp. 29-39
-
-
Rothstein, S.N.1
Little, S.R.2
-
26
-
-
0035850221
-
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
-
X. Huang, and C.S. Brazel On the importance and mechanisms of burst release in matrix-controlled drug delivery systems J Control Release 73 2001 121 136
-
(2001)
J Control Release
, vol.73
, pp. 121-136
-
-
Huang, X.1
Brazel, C.S.2
-
27
-
-
0029752042
-
Preclinical evaluation of brimonidine
-
J. Burke, and M. Schwartz Preclinical evaluation of brimonidine Surv Ophthalmol 41 Suppl. 1 1996 S9 18
-
(1996)
Surv Ophthalmol
, vol.41
, Issue.SUPPL. 1
, pp. 9-18
-
-
Burke, J.1
Schwartz, M.2
|